In this study, we identified TKI-independent upregulation of the ITIM-containing receptor FcγRIIb in primary murine leukemic stem and progenitor cells, as well as in primitive CML patient-derived CD34+ cells. This evidence concerns the gene FCGR2B and chronic myelogenous leukemia, BCR-ABL1 positive.